Table 1

Residues with largest average ΔΔG annotated with information from cBioPortal

Residue positionWild-type amino acidAnnotated mutant amino acidNumber of missense annotationsCancer typeLocation within PTEN structure
83CNANANAPhosphatase domain
95PS, L5Glioblastoma multiforme, uterine endometrioid carcinoma, colorectal adenocarcinoma and mixed germ cell tumorPhosphatase domain
96PA, L, S, T4Uterine endometrioid carcinoma, chromophobe renal cell carcinoma, glioblastoma multiforme and uterine endometrioid carcinomaPhosphatase domain
127GE, R, V15Lung adenocarcinoma, glioblastoma multiforme, hepatocellular carcinoma, cutaneous melanoma, uterine endometrioid carcinoma, colorectal adenocarcinoma, ampullary carcinoma, teratoma, uterine clear cell carcinoma and uterine serous carcinomaPhosphatase domain
132GA, C, D, S, V23Solitary fibrous tumor, uterine carcinosarcoma, glioblastoma multiforme, cutaneous melanoma, colorectal adenocarcinoma, lung adenocarcinoma, astrocytoma, uterine endometrioid carcinoma, esophageal squamous cell carcinoma, medulloblastoma, prostate adenocarcinoma and rectal adenocarcinoPhosphatase domain
151AG, T, D, V4Breast invasive lobular carcinoma, colorectal adenocarcinoma, uterine carcinosarcoma and glioblastoma multiformePhosphatase domain
165GE, R15Small cell lung cancer, renal non-clear cell carcinoma, medulloblastoma, cutaneous melanoma, glioblastoma multiforme, rectal adenocarcinoma and uterine endometrioid carcinomaPhosphatase domain
204PL, R, S7Melanoma, glioblastoma multiforme, uterine endometrioid carcinoma, uterine carcinosarcoma, colorectal adenocarcinoma and cutaneous melanomaC2 domain
213PR1Prostate adenocarcinomaC2 domain
328ANANANAC2 domain
Residue positionWild-type amino acidAnnotated mutant amino acidNumber of missense annotationsCancer typeLocation within PTEN structure
83CNANANAPhosphatase domain
95PS, L5Glioblastoma multiforme, uterine endometrioid carcinoma, colorectal adenocarcinoma and mixed germ cell tumorPhosphatase domain
96PA, L, S, T4Uterine endometrioid carcinoma, chromophobe renal cell carcinoma, glioblastoma multiforme and uterine endometrioid carcinomaPhosphatase domain
127GE, R, V15Lung adenocarcinoma, glioblastoma multiforme, hepatocellular carcinoma, cutaneous melanoma, uterine endometrioid carcinoma, colorectal adenocarcinoma, ampullary carcinoma, teratoma, uterine clear cell carcinoma and uterine serous carcinomaPhosphatase domain
132GA, C, D, S, V23Solitary fibrous tumor, uterine carcinosarcoma, glioblastoma multiforme, cutaneous melanoma, colorectal adenocarcinoma, lung adenocarcinoma, astrocytoma, uterine endometrioid carcinoma, esophageal squamous cell carcinoma, medulloblastoma, prostate adenocarcinoma and rectal adenocarcinoPhosphatase domain
151AG, T, D, V4Breast invasive lobular carcinoma, colorectal adenocarcinoma, uterine carcinosarcoma and glioblastoma multiformePhosphatase domain
165GE, R15Small cell lung cancer, renal non-clear cell carcinoma, medulloblastoma, cutaneous melanoma, glioblastoma multiforme, rectal adenocarcinoma and uterine endometrioid carcinomaPhosphatase domain
204PL, R, S7Melanoma, glioblastoma multiforme, uterine endometrioid carcinoma, uterine carcinosarcoma, colorectal adenocarcinoma and cutaneous melanomaC2 domain
213PR1Prostate adenocarcinomaC2 domain
328ANANANAC2 domain
Table 1

Residues with largest average ΔΔG annotated with information from cBioPortal

Residue positionWild-type amino acidAnnotated mutant amino acidNumber of missense annotationsCancer typeLocation within PTEN structure
83CNANANAPhosphatase domain
95PS, L5Glioblastoma multiforme, uterine endometrioid carcinoma, colorectal adenocarcinoma and mixed germ cell tumorPhosphatase domain
96PA, L, S, T4Uterine endometrioid carcinoma, chromophobe renal cell carcinoma, glioblastoma multiforme and uterine endometrioid carcinomaPhosphatase domain
127GE, R, V15Lung adenocarcinoma, glioblastoma multiforme, hepatocellular carcinoma, cutaneous melanoma, uterine endometrioid carcinoma, colorectal adenocarcinoma, ampullary carcinoma, teratoma, uterine clear cell carcinoma and uterine serous carcinomaPhosphatase domain
132GA, C, D, S, V23Solitary fibrous tumor, uterine carcinosarcoma, glioblastoma multiforme, cutaneous melanoma, colorectal adenocarcinoma, lung adenocarcinoma, astrocytoma, uterine endometrioid carcinoma, esophageal squamous cell carcinoma, medulloblastoma, prostate adenocarcinoma and rectal adenocarcinoPhosphatase domain
151AG, T, D, V4Breast invasive lobular carcinoma, colorectal adenocarcinoma, uterine carcinosarcoma and glioblastoma multiformePhosphatase domain
165GE, R15Small cell lung cancer, renal non-clear cell carcinoma, medulloblastoma, cutaneous melanoma, glioblastoma multiforme, rectal adenocarcinoma and uterine endometrioid carcinomaPhosphatase domain
204PL, R, S7Melanoma, glioblastoma multiforme, uterine endometrioid carcinoma, uterine carcinosarcoma, colorectal adenocarcinoma and cutaneous melanomaC2 domain
213PR1Prostate adenocarcinomaC2 domain
328ANANANAC2 domain
Residue positionWild-type amino acidAnnotated mutant amino acidNumber of missense annotationsCancer typeLocation within PTEN structure
83CNANANAPhosphatase domain
95PS, L5Glioblastoma multiforme, uterine endometrioid carcinoma, colorectal adenocarcinoma and mixed germ cell tumorPhosphatase domain
96PA, L, S, T4Uterine endometrioid carcinoma, chromophobe renal cell carcinoma, glioblastoma multiforme and uterine endometrioid carcinomaPhosphatase domain
127GE, R, V15Lung adenocarcinoma, glioblastoma multiforme, hepatocellular carcinoma, cutaneous melanoma, uterine endometrioid carcinoma, colorectal adenocarcinoma, ampullary carcinoma, teratoma, uterine clear cell carcinoma and uterine serous carcinomaPhosphatase domain
132GA, C, D, S, V23Solitary fibrous tumor, uterine carcinosarcoma, glioblastoma multiforme, cutaneous melanoma, colorectal adenocarcinoma, lung adenocarcinoma, astrocytoma, uterine endometrioid carcinoma, esophageal squamous cell carcinoma, medulloblastoma, prostate adenocarcinoma and rectal adenocarcinoPhosphatase domain
151AG, T, D, V4Breast invasive lobular carcinoma, colorectal adenocarcinoma, uterine carcinosarcoma and glioblastoma multiformePhosphatase domain
165GE, R15Small cell lung cancer, renal non-clear cell carcinoma, medulloblastoma, cutaneous melanoma, glioblastoma multiforme, rectal adenocarcinoma and uterine endometrioid carcinomaPhosphatase domain
204PL, R, S7Melanoma, glioblastoma multiforme, uterine endometrioid carcinoma, uterine carcinosarcoma, colorectal adenocarcinoma and cutaneous melanomaC2 domain
213PR1Prostate adenocarcinomaC2 domain
328ANANANAC2 domain
Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close